Sanofi is hosting the 2025–2026 iAwards Program, a multi-institutional initiative designed to support collaborations with academic investigators focused on early-stage, disease-relevant translational research. The goal is to accelerate promising projects toward the clinic and ultimately integrate them into Sanofi’s early-stage pipeline. 

This opportunity is intended for academic researchers whose work aligns with Sanofi’s current areas of interest, including genomic medicine, immunology and inflammation, oncology, systems biology, and rare and neurological diseases. Selected awardees will receive $150,000 in research funding for a 12-month period, along with access to Sanofi R&D expertise and guidance.

Pre-proposals must be submitted by May 16th, 2025. Only non-confidential content should be included, and submissions must follow the provided guidelines to be considered. To submit your pre-proposal, visit the application site here.